Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series

Autor: Shaoxian Sun, Phuong Le, Shubha Bagrodia, Sadayappan V. Rahavendran, Eric Zhang, Cheng Hengmiao, Cathy Xiang, Robert Steven Kania, Jing Yuan, William Farrell, Jacqui Elizabeth Hoffman, Pairish Mason Alan, Deepak Dalvie
Rok vydání: 2013
Předmět:
Zdroj: Bioorganic & Medicinal Chemistry Letters. 23:2787-2792
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2013.02.020
Popis: PI3K, AKT and mTOR, key kinases from a frequently dysregulated PI3K signaling pathway, have been extensively pursued to treat a variety of cancers in oncology. Clinical trials of PF-04691502, a highly potent and selective ATP competitive kinase inhibitor of class 1 PI3Ks and mTOR, from 4-methylpyridopyrimidinone series, led to the discovery of a metabolite with a terminal carboxylic acid, PF-06465603. This paper discusses structure-based drug design, SAR and antitumor activity of the MPP derivatives with a terminal alcohol, a carboxylic acid or a carboxyl amide.
Databáze: OpenAIRE